Product Images Xifaxan
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Xifaxan NDC 55154-6777 by Cardinal Health 107, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a figure that shows the proportion of patients without breakthrough HE over time (in days post-randomization) for XIFAXAN. The hazard ratio, confidence interval, and log-rank p-value are also provided.*
This is a graphical representation showing the proportion of patients who didn't require hospitalization related to hepatic encephalopathy (HE) after being administered a placebo. The hazard ratio for this group was 0.5 with a 95% confidence interval of 0.287 to 0.873. The log-rank p-value was 0.00120. The chart shows data up to 168 days post-randomization.*
This text seems to be a summary of medical treatment provided to a patient with a code name or identification number of "Cuil=BELENTEY". The treatment consisted of multiple phases named as "Phase 1", "Phase 2", etc. The patient was also given a symptom diary to record their symptoms daily or weekly. However, the text does not provide any information about the type of illness or symptoms the patient was experiencing.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.